1013695-70-9

Upstream product

• 1013695-66-3 5-chloro-6-(isoquinolin-3-yloxy)pyridin-3-amine 
• 16271-33-3 2,4-Dichlorobenzenesulfonyl chloride 
• 5418-51-9 5-nitro-2-hydroxypyridine 
• 22353-38-4 3-chloro-2-hydroxy-5-nitropyridine 
• 22353-40-8 2,3-dichloro-5-nitropyridine 

Relevant academic research and scientific papers

STABLE ORAL TABLET DOSAGE FORM OF AN ANTIDIABETIC COMPOUND

The invention relates to a stable oral tablet dosage form comprising an antidiabetic compound (a compound of formula (I) or a pharmaceutically acceptable salt thereof) as the active pharmaceutical ingredient, a non-ionic surfactant and one or more pharmac

METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS

The present invention relates to a method for identifying compounds that act as insulin-sensitizers. The method can include screening of test compounds in two assays of insulin sensitivity. This method can identify lead compounds for the treatment of disorders caused by insulin resistance to glucose uptake. This invention also includes methods for treating insulin resistance and related disorders.

3-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF METABOLIC DISORDERS

The picsenl invention provides novel compounds represented by the general formula (I): wherein Ar is a quinoline or isoquinoline moiety which is substituted or unsubstituted; B is -O. -S-. or -NH-: R1 is hydrogen or S(O)2R4: R2 is S(O)2R4. C(O)OR5. or C(O